24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Nucleic acids delivery methods for genome editing in zygotes and embryos: the old, the new, and the old-new

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In the recent years, sequence-specific nucleases such as ZFNs, TALENs, and CRISPR/Cas9 have revolutionzed the fields of animal genome editing and transgenesis. However, these new techniques require microinjection to deliver nucleic acids into embryos to generate gene-modified animals. Microinjection is a delicate procedure that requires sophisticated equipment and highly trained and experienced technicians. Though over a dozen alternate approaches for nucleic acid delivery into embryos were attempted during the pre-CRISPR era, none of them became routinely used as microinjection. The addition of CRISPR/Cas9 to the genome editing toolbox has propelled the search for novel delivery approaches that can obviate the need for microinjection. Indeed, some groups have recently developed electroporation-based methods that have the potential to radically change animal transgenesis. This review provides an overview of the old and new delivery methods, and discusses various strategies that were attempted during the last three decades. In addition, several of the methods are re- evaluated with respect to their suitability to deliver genome editing components, particularly CRISPR/Cas9, to embryos.

          Reviewers: Drs. Eugene Koonin and Haruhiko Siomi.

          Related collections

          Most cited references79

          • Record: found
          • Abstract: found
          • Article: not found

          Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems.

          Microbial CRISPR-Cas systems are divided into Class 1, with multisubunit effector complexes, and Class 2, with single protein effectors. Currently, only two Class 2 effectors, Cas9 and Cpf1, are known. We describe here three distinct Class 2 CRISPR-Cas systems. The effectors of two of the identified systems, C2c1 and C2c3, contain RuvC-like endonuclease domains distantly related to Cpf1. The third system, C2c2, contains an effector with two predicted HEPN RNase domains. Whereas production of mature CRISPR RNA (crRNA) by C2c1 depends on tracrRNA, C2c2 crRNA maturation is tracrRNA independent. We found that C2c1 systems can mediate DNA interference in a 5'-PAM-dependent fashion analogous to Cpf1. However, unlike Cpf1, which is a single-RNA-guided nuclease, C2c1 depends on both crRNA and tracrRNA for DNA cleavage. Finally, comparative analysis indicates that Class 2 CRISPR-Cas systems evolved on multiple occasions through recombination of Class 1 adaptation modules with effector proteins acquired from distinct mobile elements.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Knockout rats via embryo microinjection of zinc-finger nucleases.

            The toolbox of rat genetics currently lacks the ability to introduce site-directed, heritable mutations into the genome to create knockout animals. By using engineered zinc-finger nucleases (ZFNs) designed to target an integrated reporter and two endogenous rat genes, Immunoglobulin M (IgM) and Rab38, we demonstrate that a single injection of DNA or messenger RNA encoding ZFNs into the one-cell rat embryo leads to a high frequency of animals carrying 25 to 100% disruption at the target locus. These mutations are faithfully and efficiently transmitted through the germline. Our data demonstrate the feasibility of targeted gene disruption in multiple rat strains within 4 months time, paving the way to a humanized monoclonal antibody platform and additional human disease models.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century.

              Gene targeting in mouse embryonic stem cells has become the 'gold standard' for determining gene function in mammals. Since its inception, this technology has revolutionized the study of mammalian biology and human medicine. Here I provide a personal account of the work that led to the generation of gene targeting which now lies at the centre of functional genomic analysis.
                Bookmark

                Author and article information

                Contributors
                +81-99-275-5246 , masasato@ms.kagoshima-u.ac.jp
                masato@is.icc.u-tokai.ac.jp
                kettle@affrc.go.jp
                1-402-559-3338 , cgurumurthy@unmc.edu
                Journal
                Biol Direct
                Biol. Direct
                Biology Direct
                BioMed Central (London )
                1745-6150
                31 March 2016
                31 March 2016
                2016
                : 11
                : 16
                Affiliations
                [ ]Section of Gene Expression Regulation, Frontier Science Research Center, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, Kagoshima, 890-8544 Japan
                [ ]Division of Basic Molecular Science and Molecular Medicine, School of Medicine, Tokai University, Kanagawa, 259 1193 Japan
                [ ]Animal Genome Research Unit, Division of Animal Science, National Institute of Agrobiological Sciences, Ibaraki, 305-8602 Japan
                [ ]Developmental Neuroscience, Munroe-Meyer Institute, University of Nebraska Medical Center, Omaha, NE 68198 USA
                [ ]Mouse Genome Engineering Core Facility, University of Nebraska Medical Center, Omaha, NE 68198 USA
                Article
                115
                10.1186/s13062-016-0115-8
                4815204
                27037013
                becbb435-7d9a-4a57-bfee-838f55d10c9f
                © Sato et al. 2016

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 4 December 2015
                : 15 March 2016
                Funding
                Funded by: Ministry of Education, Science, Sports, and Culture, Japan.
                Award ID: 15K07695
                Funded by: FundRef http://dx.doi.org/10.13039/100000057, National Institute of General Medical Sciences;
                Award ID: P20GM103471
                Categories
                Review
                Custom metadata
                © The Author(s) 2016

                Life sciences
                genome editing,crispr/cas,pronuclaer injection,transgenic,nucleic acids delivery,mcroinjection

                Comments

                Comment on this article